Effect of a machine learning-based severe sepsis prediction algorithm on patient survival and hospital length of stay: a randomised clinical trial. by Shimabukuro, David W et al.
UCSF
UC San Francisco Previously Published Works
Title
Effect of a machine learning-based severe sepsis prediction algorithm on patient survival 


















eScholarship.org Powered by the California Digital Library
University of California
  1Shimabukuro DW, et al. BMJ Open Resp Res 2017;4:e000234. doi:10.1136/bmjresp-2017-000234
AbstrAct
Introduction Several methods have been developed to 
electronically monitor patients for severe sepsis, but few 
provide predictive capabilities to enable early intervention; 
furthermore, no severe sepsis prediction systems have 
been previously validated in a randomised study. We 
tested the use of a machine learning-based severe sepsis 
prediction system for reductions in average length of stay 
and in-hospital mortality rate.
Methods We conducted a randomised controlled clinical 
trial at two medical-surgical intensive care units at the 
University of California, San Francisco Medical Center, 
evaluating the primary outcome of average length of 
stay, and secondary outcome of in-hospital mortality rate 
from December 2016 to February 2017. Adult patients 
(18+) admitted to participating units were eligible for this 
factorial, open-label study. Enrolled patients were assigned 
to a trial arm by a random allocation sequence. In the 
control group, only the current severe sepsis detector was 
used; in the experimental group, the machine learning 
algorithm (MLA) was also used. On receiving an alert, the 
care team evaluated the patient and initiated the severe 
sepsis bundle, if appropriate. Although participants were 
randomly assigned to a trial arm, group assignments were 
automatically revealed for any patients who received MLA 
alerts.
results Outcomes from 75 patients in the control and 67 
patients in the experimental group were analysed. Average 
length of stay decreased from 13.0 days in the control to 
10.3 days in the experimental group (p=0.042). In-hospital 
mortality decreased by 12.4 percentage points when using 
the MLA (p=0.018), a relative reduction of 58.0%. No 
adverse events were reported during this trial.
conclusion The MLA was associated with improved 
patient outcomes. This is the first randomised controlled 
trial of a sepsis surveillance system to demonstrate 




Severe sepsis affects more than 700 000 indi-
viduals in the USA each year1 at a cost of 
more than 20 billion dollars.2 While sepsis 
definitions vary, including the recent third 
international consensus definitions,3 here 
we define severe sepsis as ‘organ dysfunction 
caused by sepsis’,4 and sepsis as a dysregulated 
host response to infection.5 Severe sepsis has 
an estimated annual mortality of 250 000,1, 6 
but early diagnosis has been shown to reduce 
delays in treatment, increase appropriate care 
and reduce mortality.7, 8 
In prior studies, we have demonstrated 
the efficacy of a machine learning algorithm 
(MLA) developed by Dascena (Hayward, 
California, USA) for the early prediction 
of sepsis, severe sepsis and septic shock.9–11 
Requiring inputs of only the most commonly 
recorded measurements in the electronic 
health record (EHR), primarily vital signs 
and age, the MLA predicted sepsis with 
accuracy which was superior to disease 
severity scoring systems in current use, such 
as the Sequential Organ Failure Assess-
ment (SOFA),12 the Systemic Inflammatory 
Response Syndrome (SIRS) criteria13 and the 
Modified Early Warning Score (MEWS).14 
At the time of severe sepsis onset, the MLA 
achieved an area under the receiver oper-
ating characteristic (AUROC) curve of 
0.880 (SD=0.006) compared with 0.725, 
0.609 and 0.803 for SOFA, SIRS and MEWS, 
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Key messages
 ► This study represents the first randomised 
controlled trial for a machine learning-based sepsis 
prediction algorithm to demonstrate statistically 
significant differences in length of stay and 
in-hospital mortality.
 ► The algorithm uses only six vital signs to provide 
higher sensitivity and specificity than commonly 
used sepsis scoring systems.
 ► This is a single-centre study in the intensive care 
unit only. We plan to address limited generalisability 
in further studies and algorithm development.
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respectively.9 Although these disease severity scoring 
systems were designed to predict patient risk, rather than 
specifically to identify sepsis, they are commonly used 
in severe sepsis diagnostic criteria due to their designed 
purposes of identifying systemic inflammation as a sign of 
possible infection and detecting possible organ dysfunc-
tion. Because of their close relation to sepsis diagnostic 
criteria, the clinical utility of such scoring systems for 
identifying patients with sepsis has been closely studied in 
the literature.15 16 These scoring systems therefore serve 
as important comparators for any newly developed severe 
sepsis prediction system. Though relatively new additions 
to the field of sepsis care, MLAs have the potential to 
greatly improve patient outcomes through their accu-
racy and advanced warning of impending sepsis onset, 
making studies of such tools of great importance. The 
MLA used in this study has been described at length in 
previous peer-reviewed publications.9–11
MLAs for sepsis prediction17 have primarily been tested 
retrospectively or investigated non-interventionally.18–22 
Here, we report a prospective, randomised controlled 
study, in which an algorithm was applied to EHR data 
for the prediction of severe sepsis (in a manner akin 
to a biomarker) and if warranted, generated real-time 
telephonic notifications at the University of California, 
San Francisco (UCSF) Medical Center (San Francisco, 
California, USA). We tested the hypothesis that the use of 
an MLA would result in reductions in the average length 
of stay (LOS) and the in-hospital mortality rate. To the 
best of the authors’ knowledge, this present work repre-
sented the first time a machine learning-based sepsis 
prediction system has been investigated in a randomised, 
interventional design.
The design of this study involved little or no risk of 
harm but conferred a large potential benefit. Specifically, 
the prediction algorithm’s ability to identify patients 
with severe sepsis before onset provided the opportunity 
for early intervention, which has been widely shown to 
decrease patient mortality.23 24 Kumar et al 7 found that 
survival decreased by 7.6% for every hour in which anti-
microbial therapy is not administered to patients with 
septic shock following the first hour after onset. Although 
there is some controversy about the conclusions drawn 
by Kumar et al about the linear relationship between 
antibiotic timing and survival, as well as concerns that 
the researchers did not properly consider confounding 
factors in reporting their outcomes, conflicting evidence 
has largely shown that waiting to administer patho-
gen-specific antibiotics until after confirmation of a posi-
tive microbiology is associated with improved patient 
outcomes.25 Therefore, early identification of patients 
with severe sepsis still provides a large potential benefit 
by providing an opportunity for earlier confirmation of 
infection. If the MLA produced an alert when a patient 
was not trending towards severe sepsis (false positive), 
there was no direct harm to the patient, but clinicians 
would incur additional burden to assess the patient and 
dismiss the false alert. However, with the algorithm’s high 
specificity (as demonstrated by its high AUROC value),9–11 
this risk was minimised. In the case that the algorithm 
did not identify a patient trending towards severe sepsis 
(false negative), there was no risk of additional harm, 
since UCSF’s current rules-based severe sepsis detection 
system was still active.
Methods
enrolment and study design
From December 2016 to February 2017, we conducted 
a randomised clinical trial (Trial Registration:  Clinical-
Trials. gov NCT03015454) in two mixed medical-surgical 
intensive care units (ICUs) at the UCSF Medical Center 
at Parnassus Heights. Across both units, the MLA moni-
tored a total of 32 patient beds. This study was approved 
by the UCSF Institutional Review Board with a waiver of 
informed consent for all patients.
During the study period, all patients over the age of 
18 admitted to the participating units were automatically 
enrolled in the trial. A patient admitted with a sepsis 
diagnosis was still monitored by the prediction algo-
rithm for potential further septic episodes; thus, these 
patients were not excluded from the trial. Enrolment 
entailed that a patient’s vital signs and selected lab results 
were abstracted from UCSF’s EHR software, APeX, into 
the prediction algorithm. APeX was developed by Epic 
Systems (Verona, Wisconsin, USA), and the prediction 
algorithm was developed by Dascena (Hayward, Cali-
fornia, USA).
Patients were assigned to the experimental group or 
control group based on a random allocation sequence, 
generated by a computer program using simple rando-
misation before the start of the trial. This allocation 
sequence was concealed within a vector in the backend of 
the prediction algorithm software. Healthcare providers, 
patients and investigators were thus unaware of patient 
assignment, although group assignments were naturally 
revealed for patients who generated MLA alerts. The 
programme drew 10 000 samples from a probability 
distribution with P(x=0)=0.50 and P(x=1)=0.50 for each 
sample, x. Participants assigned ‘0’ were placed in the 
control group by the application, and patients assigned a 
‘1’ were placed in the experimental group. This method 
was designed to achieve a 1:1 allocation ratio.
Patients were enrolled in accordance with the trial 
period, during which we estimated that approximately 
150 participants would be enrolled. The trial had a 
factorial, open-label design, and healthcare providers, 
patients and investigators were not made aware of group 
assignment but could not be fully blinded as some group 
assignments became naturally revealed upon receipt of 
MLA alerts.
Patients in the control group received the normal 
standard of care and were monitored by the existing 
EHR-based severe sepsis detector, which uses thresh-
old-based cut-offs of SIRS criteria and end-organ dysfunc-
tion haemodynamic or lab results.26 UCSF recognised 
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severe sepsis as organ dysfunction caused by infection 
as defined by the Surviving Sepsis Campaign.27 Clinician 
suspicion of infection was required for diagnosis, though 
identification of the infectious agent through a posi-
tive culture was not required to diagnose severe sepsis. 
The standard of care consisted of a nurse evaluation 
of the patient at the bedside for suspicion of infection. 
Nurse evaluation included assessment of patient vital 
signs, EHR notes, laboratory results such as white blood 
cell (WBC) count and results of any additional testing 
ordered. If severe sepsis was suspected, a physician subse-
quently assessed the patient and placed an order for 
administration of the standard UCSF sepsis bundle (see 
online supplementary materials).
In the experimental group, patients were monitored 
by the MLA, in addition to the existing severe sepsis 
detector. If the algorithm predicted severe sepsis for 
a given patient, a phone call was placed to the charge 
nurse on duty; however, no recommendations for treat-
ment were provided with the notification. The charge 
nurse then followed UCSF’s standard severe sepsis evalu-
ation and intervention process. Alternatively, if the MLA 
has failed to forecast severe sepsis for a given patient, the 
existing UCSF severe sepsis detector may have identified 
the patient at a later time. Participants received the same 
severe sepsis assessment and treatment, regardless of 
which system predicted or detected their severe sepsis. 
Thus, the trial was designed to demonstrate the supe-
riority of using an algorithmic predictor relative to the 
hospital’s current EHR-native rules-based severe sepsis 
surveillance system.
data collection and analysis
Demographic information and clinical measurements 
were collected from each enrolled patient’s medical 
record. All patient data were collected from admission 
to discharge in the participating units, although partici-
pants were followed until hospital discharge in order to 
determine in-hospital mortality and overall LOS.
Using the required measurements (systolic/diastolic 
blood pressure, heart rate, temperature, respiratory rate, 
peripheral capillary oxygen (SpO2) and age), the MLA 
monitored patients hourly. The MLA also incorporated 
additional optional inputs as they were available (selected 
labs, eg, pH, WBC count, glucose). A full list of variables 
collected by the MLA is available as online supplemental 
table S1. The machine learning-based classifiers in the 
algorithm were used to generate a risk score predictive of 
severe sepsis. These classifiers analysed multidimensional 
patterns and time-series trends to improve severe sepsis 
forecasting.11 The resulting risk score ranged between 0 
and 100 for each patient, and if it exceeded the preset 
threshold of 80, the charge nurse was called.
At the conclusion of the clinical trial, we evaluated 
the primary outcome (average hospital LOS) and 
secondary outcome (in-hospital mortality rate) as well 
as ICU LOS, using outcome-related measurements 
(online supplemental table S1) which were collected 
for all enrolled patients. Given the high historical sepsis 
prevalence in the study units,26 sepsis-related LOS and 
mortality were expected to be sufficiently represented 
in these more general outcome metrics. Additionally, 
we retrospectively compared algorithm performance 
on patient data from the study with the performance of 
MEWS, SIRS, SOFA and the quick SOFA (qSOFA) score 
on the same prospectively collected data. No interim 
analyses were performed before the conclusion of the 
trial.
statistical analysis
The desired sample size for this study was calculated 
to detect a reduction of 1.5 days in hospital LOS at a 
power of 0.80 and a type I error rate of 0.05. Two-sample 
t-tests were used to determine if there was a statistically 
significant difference in means between the experi-
mental and control groups for hospital LOS and for 
ICU LOS. We used the two-proportion (risk difference) 
and relative risk (risk ratio) z-tests to determine if there 
was a statistically significant decrease in the in-hospital 
mortality rate with the use of the predictive algorithm. 
All tests were single tailed with an alpha level of 0.05, 
and were performed using the MATLAB software 
(V.R2016a) developed by MathWorks (Natick, Massa-
chusetts, USA).
results
Patient inclusion and baseline characteristics
During the course of the trial period, 142 patients from 
the participating units were assessed for eligibility. Patient 
enrolment was stopped before the projected enrolment 
size of 150 due to the conclusion of the study period. 
Of those patients, all met the inclusion criteria, as none 
were younger than 18 years of age. This resulted in the 
randomisation of 142 patients, 75 of which were assigned 
to the control group and the other 67 assigned to the 
experimental group (figure 1). No patients were lost to 
follow-up since participants were tracked throughout 
their hospital stay, and the study did not require patients 
to return for additional intervention or questioning. The 
outcomes of all 142 participants were analysed, and the 
trial concluded at that point.
Demographic and clinical characteristics were collected 
for all patients (table 1). There were 53.5% women and 
46.5% men in this study, and the average age of partic-
ipating patients was 59 years old (SD=16.5 years). No 
differences in demographic distributions between the 
two arms of the study were statistically significant. The 
top three routes of admission for patients in both arms 
were, in ranked order, the emergency department, the 
transfer centre and UCSF’s medical-surgical high acuity 
ward.
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Figure 1 Patients assessed, enrolled, randomised and analysed in each arm of the randomised controlled trial.
outcomes
The primary outcome, average hospital LOS, was 13.0 
days in the control group and 10.3 days in the experi-
mental group, representing a 20.6% reduction (figure 2, 
table 2). This decrease was statistically significant with a 
95% one-sided confidence interval (CI) with an upper 
bound of −3.08 hours. Similarly, average ICU LOS was 
8.40 days in the control group and 6.31 days in the exper-
imental group (table 2). Using a two-sample t-test, we 
found a statistically significant decrease in ICU LOS with 
a 95% one-sided CI with an upper bound of −6.30 hours.
To assess the secondary outcome, for each of the 142 
patients we tabulated the number of in-hospital deaths 
within each group and divided by the number of total 
group members. The control group contained 16 
out of 75 patients with in-hospital mortality, while the 
experimental group had 6 in-hospital fatalities out of 
67 patients (figure 3, table 2). There was a statistically 
significant decrease in the difference of in-hospital 
mortality rate, with a one-sided 95% CI with an upper 
bound of −0.0271. There was also a statistically signif-
icant decrease in the risk ratio of in-hospital mortality 
rate (p=0.026), with a 95% CI with an upper bound of 
0.880. Therefore, in-hospital mortality decreased by 12.4 
percentage points in the experimental group, a 58.0% 
relative decrease. One patient included in the study was 
discharged to hospice care. This patient was randomised 
to the control group, and was treated as ‘alive’ for the 
purposes of calculating in-hospital mortality.
Patient outcomes also improved in the experimental 
group for the subpopulation of patients who received 
International Classification of Diseases 10 codes for 
sepsis, severe sepsis or septic shock (online supplemental 
table S2). For these patients, the average hospital LOS 
was 16.8 days in the control group and 9.83 days in the 
experimental group (p=0.042). For the same subpopula-
tion, the mortality rate was 40.0% in the control group 
and 13.6% in the experimental group (p=0.023).
Patients in the experimental group additionally 
received antibiotics an average of 2.76 hours earlier than 
patients in the control group, and had blood cultures 
drawn an average of 2.79 hours earlier than patients in the 
control group. Of the 75 patients in the control group, 39 
were administered antibiotics and 30 had blood cultures 
drawn. Of the 67 patients in the experimental group, 31 
received antibiotics and 22 had blood cultures drawn.
On physiological data collected during the study from 
the enrolled participants, the algorithm more accurately 
detected severe sepsis than MEWS, SIRS criteria, the 
SOFA score or the qSOFA score in a retrospective analysis 
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Figure 2 Decrease in average hospital and ICU length of 
stay with the use of the machine learning algorithm. The 
error bars represent one standard error above and below 
the mean length of stay. ICU, intensive care unit.
Table 1 Patient demographics and comorbidities in the 





Male, count (%) 31 (41) 35 (52) 0.09
Age, mean (SD) 59.3 (16.3) 58.9 (16.8) 0.49
Race and ethnicity, count (%)
  White 36 (48) 30 (45) 0.35
  African American 10 (13) 6 (9.0) 0.21
  Asian American 13 (17) 9 (13) 0.26
  Hispanic 13 (17) 17 (25) 0.12
  Other 3 (4.4) 5 (7.5) 0.18
Comorbidities, count (%)
  Sepsis 9 (12) 16 (24) 0.03








  Cardiovascular 17 (23) 14 (21) 0.39
  Renal 10 (13) 8 (12) 0.40
  Liver 4 (5.3) 3 (4.5) 0.41
  Organ transplant 10 (13) 11 (16) 0.30
  HIV positive 2 (2.7) 2 (3.0) 0.45
  Mental health 
disorder 2 (2.7) 1 (1.5) 0.31
  Diabetes 9 (12) 9 (13) 0.40
  COPD 3 (4) 1 (1.5) 0.18
  Cancer 26 (35) 32 (48) 0.06
  Alcohol abuse 4 (5.3) 1 (1.5) 0.11
  Pneumonia 7 (9.3) 6 (9) 0.47
Comorbidities are based on International Classification of 
Diseases 10 codes (see online supplemental table S2). P value 
for statistically significant differences in the distribution of 
demographics were calculated with a two-proportion z-test for all 
categorical variables, and a two-sample t-test for the continuous 
variable (age). Significance was set at 0.05. 
COPD, Chronic Obstructive Pulmonary Disease. 
(table 3). Our gold standard for severe sepsis was defined 
as patients meeting two SIRS criteria and two organ 
dysfunction criteria within the same hour (see online 
supplementary materials).
No harms with respect to either intervention were 
reported throughout the duration of the trial. Similarly, 
no adverse events were observed in the experimental 
group. The outcomes data indicated clear benefits in 
LOS and mortality reduction when using the predictive 
algorithm over the EHR-based sepsis detector.
dIscussIon
The use of the machine learning-based predictor resulted 
in significant decreases in LOS and in-hospital mortality 
rate during this randomised controlled trial. Specifi-
cally, we found a 20.6% decrease in average hospital LOS 
from 13.0 to 10.3 days (p=0.042) and a 12.4% decrease 
in in-hospital mortality rate from 21.3% to 8.96% 
(p=0.018) when using the MLA. While one patient 
from the control group of the study was discharged 
to hospice care, changing the mortality classification 
of this patient would not have impacted the results of 
the mortality analysis in this study. Decreases in average 
hospital LOS and in-hospital mortality were also found 
in the experimental group among the subpopulation 
of patients diagnosed with sepsis, severe sepsis or septic 
shock. Additionally, improvement was found in time 
to blood culture draws and antibiotic administration 
in the experimental group. We have demonstrated 
past success with retrospective applications of sepsis 
detection methods,9–11 as well as mortality prediction 
methods28 29; this study suggested that these retro-
spective successes will translate into improved clinical 
outcomes.
Past randomised controlled trials investigating 
electronic sepsis monitoring tools have failed 
to achieve statistically significant outcomes for 
reduction of in-hospital mortality rate and LOS, 
and improvement in bundle compliance30 31  
(online supplemental table S3). Semler et al imple-
mented an electronic sepsis alerting tool based on a 
series of logic rules in two ICUs. While they aimed to 
improve bundle compliance and clinical outcomes, 
they did not find a statistically significant difference 
in time to intervention, and their tool was underused 
by clinicians.31 Similarly, Hooper et al installed a sepsis 
surveillance system that alerted clinicians when two 
or more modified SIRS criteria were met. They were 
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Table 2 Differences in hospital LOS, ICU LOS, and in-hospital mortality between the experimental and control groups
Outcome Control (n=75) Experimental (n=67) Amount of reduction P value
  Hospital LOS (days) 13.0 (1.23) 10.3 (0.912) 2.30 days 0.042
  ICU LOS (days) 8.40 (0.881) 6.31 (0.666) 2.09 days 0.030
  In-hospital mortality rate 21.3% (4.76%) 8.96% (3.51%) 12.3% 0.018
The mean and the standard error (in parentheses) for each outcome are noted in the table. All outcomes demonstrate statistically significant 
reductions when using the  machine learning algorithm (p<0.05).
ICU, intensive care unit; LOS, length of stay.
Figure 3 Reduction of in-hospital mortality rate when 
using the machine learning algorithm. The error bars 
represent one standard error above and below the average 
in-hospital mortality rate.
Table 3 Comparison of AUROC, sensitivity and specificity 
for the MLA applied to severe sepsis detection and SIRS 
criteria, MEWS, the SOFA score and the qSOFA score on 
patient physiological data collected during the study
MLA SIRS MEWS SOFA qSOFA
AUROC 0.952
(0.946 to 0.958)
0.681 0.524 0.756 0.518
Sensitivity 0.900
(0.870 to 0.930)
0.590 0.365 0.910 0.288
Specificity 0.900
(0.878 to 0.922)
0.764 0.667 0.181 0.750
A 95% CI for the MLA is also included in parentheses.
AUROC, area under the receiver operator characteristic curve; 
MEWS, Modified Early Warning Score; MLA, machine learning 
algorithm; SIRS, Systemic Inflammatory Response Syndrome; 
qSOFA, quick Sequential Organ Failure Assessment.
unsuccessful in showing reduced LOS and time to 
bundle compliance in the ICU.30
Unlike previous randomised clinical trials, several 
prospective observational studies have shown improve-
ments in severe sepsis-related clinical or patient 
outcomes. In a recent before-and-after study, Manak-
tala and Claypool32 reported a 53% relative decrease 
in the sepsis-related in-hospital mortality rate (p=0.03) 
through the implementation of a complex rules-
based sepsis alerting system. Although not based on 
machine-learning models, the study by Manaktala and 
Claypool demonstrates the potential for large improve-
ments in patient outcomes with the implementation 
of advanced sepsis surveillance, and the present work 
provides further evidence in that direction. Similarly, 
the prospective studies of both Sawyer et al22 and Berger 
et al33 achieved statistically significant decreases in time 
to clinical intervention for patients who triggered a 
sepsis alert. Though they did not provide evidence of 
improved patient outcomes, the results of these studies 
indicate the potential for reductions in key clinical 
metrics using automated sepsis surveillance systems. 
See online supplemental table S3 for a full comparison 
of recent studies and associated outcomes.
The broader sepsis screening literature primarily 
consists of rule-based thresholds for alerts, triggered 
when predetermined criteria are met. These systems, 
unlike the present work, generally detect, not predict, 
a sepsis syndrome.30 33 There is likely a relationship 
between this algorithm’s significant improvements in 
patient outcomes and its design to predict severe sepsis 
up to 4 hours in advance.11 Predictions made by the MLA 
in this study likely also influenced the septic shock counts 
observed in table 1. With extra time to intervene in the 
experimental group, patients may not have ultimately 
progressed to septic shock, thus producing different 
prevalences in the experimental (1.5%) and control 
(5.3%) groups. This interpretation was supported by the 
higher proportion of patients diagnosed with sepsis in 
the experimental arm of the trial; this higher proportion 
implied that sepsis was detected and treated earlier in 
the experimental group, thereby deterring progression 
to septic shock.
In addition to the algorithm’s predictive nature, 
improvements in patient outcomes likely reflected the 
MLA’s combination of high sensitivity and high spec-
ificity.10 11 This reasoning is in close alignment with 
Manaktala and Claypool’s study.32 Sepsis scoring systems 
such as SIRS and SOFA often correctly identify patients 
with sepsis, maintaining a high sensitivity, but have low 
specificities, incorrectly classifying non-septic patients. 
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Systems that use these scores deliver many false alarms, 
which could impact a clinician’s willingness to use the 
sepsis classification tool.34 The prediction algorithm may 
have been more readily used compared with other sepsis 
classification systems with lower specificities.
Moreover, several of the models described in the liter-
ature require multiple laboratory test results, which may 
not be ordered if clinicians do not suspect sepsis. Some 
also require specialist annotation and interpretation of 
clinical notes. In contrast, this MLA required only vital 
signs and age to forecast sepsis onset several hours early,11 
and was additionally able to incorporate optional labora-
tory results when they were available for accurate fore-
casting using a range of possible clinical measurements. 
This aspect of the algorithm may have also contributed to 
improved outcomes in this randomised controlled trial.
limitations
The present work was a single centre randomised 
controlled trial conducted at the UCSF Medical 
Center, which treats a fairly heterogeneous 
patient population, relative to US national 
averages. Thus, this finding may be less generalisable to 
institutions whose patient populations are more homo-
geneous with similar demographics and comorbidities 
among patients. Further, because this trial was conducted 
in two ICUs, we cannot generalise the algorithm’s perfor-
mance in this study to other wards such as the emer-
gency department or floor units, where data collection 
frequency and admission diagnoses differ. The small 
sample size used in this study, the short study period and 
the single season over which the study was conducted 
additionally limit generalisability of these results.
In previous studies, this MLA has been shown to predict 
sepsis, severe sepsis and septic shock several hours early 
with a higher sensitivity and specificity than rules-based 
sepsis screening approaches.11 These metrics were not 
monitored prospectively during the study due to the likely 
misrepresentation of such results. With advanced notice 
from the predictive algorithm, clinicians may have initi-
ated treatment before severe sepsis onset, thus averting 
the diagnosis. These cases could be documented as false 
positives, skewing the prediction algorithm’s sensitivity.
We are unable to rule out the possibility that the predic-
tive algorithm improved clinical outcomes by improving 
clinician awareness of high-risk patients rather than by 
predicting sepsis early. Further, we did not implement 
any precautionary measures which prevented clinicians 
from more closely monitoring patients in the exper-
imental arm of the trial after MLA alerts were gener-
ated. However, this is likely reflective of the type of care 
known high-risk patients typically receive, and may there-
fore illustrate the algorithm’s expected performance 
in future care settings. Additionally, the use of overall 
metrics, LOS and in-hospital mortality for all comers, 
rather than sepsis-specific LOS and mortality as primary 
and secondary outcomes, may underestimate the impact 
of the intervention on outcomes for patients with sepsis.
An additional limitation is the potential for competing 
risks in the selected endpoints. Because mortality may 
shorten a patient’s LOS, there is some inevitable censoring 
when measuring changes in the two outcomes. The actual 
reduction in LOS for patients who were monitored by the 
MLA could have been larger than reported in this study, 
given the lower mortality rate in the experimental group. 
However, we did not have the data required to calculate 
additional metrics such as hospital free days out of 30 and 
therefore could not use these metrics in order to manage 
the competing risks of the selected endpoints. Further, 
this study was patient outcome-oriented; in future work, 
we plan to more thoroughly study endpoints related to 
clinical workflow and interventional actions such as time 
to fluid bolus administration.
conclusIon
In this clinical trial, we demonstrated improvements in 
patient outcomes when using a machine learning-based 
sepsis prediction algorithm. We found a statistically 
significant decrease in the hospital LOS and in-hospital 
mortality when using this algorithm compared with the 
current rules-based sepsis detector. From these results, 
we deduced that machine learning-based sepsis predic-
tion algorithms may lead to earlier clinical interven-
tion and improved patient outcomes. Some limitations 
of this study include its containment to a single centre 
and to ICUs only. In future studies, we intend to vali-
date the MLA’s performance in hospitals with varying 
demographic and clinical characteristics as well as in 
non-critical care units. 
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